Inspira Technologies is making a bold step into the cancer diagnostics field. They've signed a preliminary deal to buy a company that specializes in liquid biopsy technology. This tech can detect cancer cells in blood samples using AI. The deal also includes a $15 million investment from an unnamed
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting condition that strikes young children. It's caused by a problem in a massive gene called DMD. For a long time, doctors have used muscle biopsies to diagnose and track DMD. But these procedures can be risky and uncomfortable. That's where b
A new method is making waves in the world of cancer detection. This method is called liquid biopsy. It is a simple blood test that can spot cancer signs. It is not a new idea but it is not well studied. This is especially true for a specific type of cancer. Pancreatic cancer is tough to catch e
